Theralase Technologies Inc. V.TLT

My reference point on pricing

[DJDawg]

I was early on a stock called LOXO. They made a successful drug for sold tumours with a very specific genetic mutation. Not as big a target market as TLT would aim for one day with IV Rutherrin.

LOXO was bought out for 6B usd (Bayer).

If TLT ever reached that (who knows....) that would mean a share price closer to 20 USD.

Nice to dream sometimes.

[Pandora]

And did the LOXO drug become a success after being bought out by Bayer or did it get lost in the big pharma swamp?

[DJDawg]

It was bought by big pharma. Very successful drug in that it works and is very profitable. However, can't speak to what portion of Bayer's profits are from it. It is for a very specific mutated tumour type. I bought the stock because I knew a family in the neighbourhood whose 5yr old son was on oxygen (lung mets) and palliative. He enrolled in the phase 2 trial with LOXO. I bumped into